Eden Research (LON:EDEN) Trading Down 3.3% – Should You Sell?

Eden Research plc (LON:EDEN)’s stock price fell 3.3% during mid-day trading on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The business has a 50 day simple moving average of GBX 3.88 and a two-hundred day simple moving average of GBX 3.95. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The firm has a market capitalization of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92.

Insider Activity

In other news, insider Lykele van der Broek acquired 256,000 shares of Eden Research stock in a transaction that occurred on Thursday, February 6th. The stock was bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey bought 540,540 shares of the stock in a transaction on Tuesday, January 28th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.